Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Atrayee Basu-Mallick
PTEN Gene Expression and Mutations in the PIK3CA Gene as Predictors of Clinical Benefit to Anti-Epidermal Growth Factor Receptor Antibody Therapy in Patients With KRAS Wild-Type Metastatic Colorectal Cancer
Clinical Colorectal Cancer
Oncology
Gastroenterology
Related publications
Vitamin D Receptor Expression Is Associated With PIK3CA and KRAS Mutations in Colorectal Cancer
Cancer Epidemiology Biomarkers and Prevention
Medicine
Epidemiology
Oncology
Anti-Epidermal Growth Factor Receptor Gene Therapy for Glioblastoma
PLoS ONE
Multidisciplinary
Association Between Serum Ligands and the Skin Toxicity of Anti-Epidermal Growth Factor Receptor Antibody in Metastatic Colorectal Cancer
Cancer Science
Cancer Research
Medicine
Oncology
EGFR Protein Expression in KRAS Wild-Type Metastatic Colorectal Cancer Is Another Negative Predictive Factor of the Cetuximab Therapy
Cancers
Cancer Research
Oncology
Patterns of Use and Tolerance of Anti–Epidermal Growth Factor Receptor Antibodies in Older Adults With Metastatic Colorectal Cancer
Clinical Colorectal Cancer
Oncology
Gastroenterology
Impact of Epidermal Growth Factor Receptor Gene Expression Level on Clinical Outcomes in Epidermal Growth Factor Receptor Mutant Lung Adenocarcinoma Patients Taking First-Line Epidermal Growth Factor Receptor–tyrosine Kinase Inhibitors
Tumor Biology
Medicine
Cancer Research
Vascular Endothelial Growth Factor Plus Epidermal Growth Factor Receptor Dual Targeted Therapy in Metastatic Colorectal Cancer: Synergy or Antagonism?
Journal of Oncology
Oncology
FOLFIRI Plus Panitumumab in the Treatment of Wild-Type KRAS and Wild-Type NRAS Metastatic Colorectal Cancer
World Journal of Surgical Oncology
Surgery
Oncology
Emergence of KRAS Mutations and Acquired Resistance to Anti-Egfr Therapy in Colorectal Cancer
Nature
Multidisciplinary
